Is there a role for bevacizumab in the primary treatment of advanced ovarian cancer off-protocol? Journal Article
| Authors: | Meisel, J. L.; Sabbatini, P. |
| Article Title: | Is there a role for bevacizumab in the primary treatment of advanced ovarian cancer off-protocol? |
| Keywords: | combination chemotherapy; angiogenesis inhibitors; clinical trials; anti-vegf agents; front line ovarian cancer |
| Journal Title: | Clinical Ovarian and other Gynecologic Cancer |
| Volume: | 5 |
| Issue: | 2 |
| ISSN: | 2212-9553 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2012-12-01 |
| Start Page: | 48 |
| End Page: | 50 |
| Language: | English |
| DOI: | 10.1016/j.cogc.2013.12.003 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 3 March 2014 -- Source: Scopus |
